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Abstract
Purpose: Arteriovenous malformations (AVMs) are connected with cerebral haemorrhage, seizures, increased intrac-
ranial pressure, headaches, mass effect, and ischaemia symptoms. Selection of the best treatment method or even 
deciding if intervention is required can be difficult. 
Material and methods: The study included 50 patients who were diagnosed with cerebral AVMs and treated in our 
Centre between 2008 and 2014. A total of 111 procedures were performed, including 94 endovascular embolisations 
and 17 neurosurgical procedures. Medical records and imaging data were reviewed for all patients. All AVMs were 
measured and assessed, allowing classification in Spetzler-Martin and Spetzler-Ponce scales. 
Results: Complete or partial treatment was observed in 88.24% of neurosurgical procedures and in 84.00% of em-
bolisations. Early complication rate was 21.28% for embolisation and 17.65% for neurosurgical procedures, while 
Glasgow Outcome Scale was 4.89 (σ = 0.38) and 5.0 (σ = 0.00), respectively. According to the Spetzler-Martin scale, 
cerebral haemorrhages occurred more frequently in grade 1, but no statistical significance was observed. In Spetzler- 
Ponce class B lower grades in Glasgow Coma Scale (GCS) were noticed (p = 0.02). Lower GCS scores were also 
correlated with deep location of AVM and with eloquence of adjacent brain. Patients with Spetzler-Martin grade 1 
were more frequently qualified for neurosurgical procedures than other patients.
Conclusions: Treating AVMs requires coordination of a multidisciplinary team. Both endovascular embolisation and 
neurosurgical procedure should be considered as a part of multimodal, frequently multistage treatment. Spetzler- 
Martin and Spetzler-Ponce scales have an influence on haemorrhage frequency and patients’ clinical condition and 
should be taken into consideration in selecting the treatment method.
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Introduction
Cerebral arteriovenous malformations (AVMs) are rare 
intracranial findings usually presenting with haemorrhage 
and annual risk of bleeding accounting for 2-4% [1,2]. 
Other clinical presentations of AVMs besides intracranial 
haemorrhage include seizures, headache, and focal neuro-
logical deficits [1,2]. The main goal of treatment of AVMs 
is to eliminate the risk of the most serious and common 
complication, which is intracranial haemorrhage, and to 
preserve the patient’s functional status [2-4]. Several treat-
ment options for patients with AVMs include conservative 
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treatment, neurosurgery, radiosurgery, or endovascular 
obliteration [1,5].
Material and methods
Patient population 
Between 2008 and 2014, 50 patients with medium age 
38.20 years (σ = 13.56) were diagnosed with AVMs 
and were qualified for invasive treatment in our Centre 
(Table 1). The studied population consisted of 18 women 
(36%) and 32 men (64%).
Two invasive methods of AVMs treatment were used 
in our Centre: neurosurgical procedure and endovascular 
embolisation. A total of 111 procedures were performed, 
including 17 neurosurgical (mean age: 34.88 years, 
σ = 11.02) and 94 endovascular (mean age: 38.56 years, 
σ = 13.86) procedures. If the patients had not been qual-
ified to invasive treatment in our Centre, conservative 
treatment was implemented or the patient was referred to 
radiosurgery in other centres. 
The diagnostic scheme consisted of qualification based 
on the patient’s clinical presentation and DSA imaging. 
The choice of the preferred strategy was made by an inter-
disciplinary team composed of neurosurgeons and inter-
ventional neuroradiologists. 
Arteriovenous malformations characteristics  
and qualification for treatment
Medical records were reviewed for all patients. Presence 
of haemorrhage, Glasgow Coma Scale [6] (GCS) score, 
neurological symptoms, and co-morbidities on admis-
sion to hospital were assessed. In a group of 37 patients 
with intracranial bleeding 35 presented with intracerebral 
haemor rhage and two with subarachnoid haemorrhage 
(SAH). Due to the small amount of SAH no differenti-
ation into types of haemorrhage in further analysis was 
performed. 
Each patient underwent 3D digital subtraction angio-
graphy (DSA). Other imaging data were not mandatory 
but assessed if available. Assessed parameters of AVMs 
involved: location (side and lobes), superficial or deep 
localisation, localisation of the AVM in eloquent or non- 
eloquent areas of the brain, feeding arteries (amount and 
type), venous drainage, size of nidus, and presence of 
an AVM-associated aneurysm. Superficial AVM was de-
fined as pail with the stipulation that no part of the ni-
dus can be localised deeper than 1 cm. Superficial venous 
drainage was defined as drainage to superior sagittal si-
nus or transverse sinus. Any other drainage, including 
sigmoid sinus, was considered as deep venous drainage. 
The gathered data allowed us to classify all AVMs in Spet-
zler-Martin [7] and Spetzler-Ponce [8] scales.
Treatment methods
The amount of endovascular embolisation and neurosur-
gical procedures was analysed. It was taken into consid-
eration if the procedure was a first-choice treatment or 
followed any other invasive treatment. The effectiveness 
of treatment, ICU, neurosurgery ward stay after the pro-
cedure, and presence of early complications were also as-
sessed. The Glasgow Outcome Scale [9] (GOS) was used 
to evaluate patients’ clinical condition on discharge.
Statistical analysis
Influence of Spetzler-Martin and Spetzler-Ponce scales on 
GCS scores was calculated using ANOVA Kruskal-Wallis 
test. In other cases nonparametric tests, like Mann-Whit-
ney U test, were used due to small samples in subgroups. 
All statistical analysis was performed by StatSoft Statistica 
v12.5.
Results
Nineteen and 42 AVMs were evaluated in Spetzler-Martin 
scale as grades 1 and 2, respectively. Because Spetzler-Ponce 
scale class A includes grades 1 and 2 of the Spetzler-Martin 
scale, 61 AVMs (55%) were qualified to this group. For-
ty-seven AVMs (42%) were evaluated as grade 3 and subse-
quently class B. With only three AVMs in grade 4 and none 
in grade 5, class C consists of only three AVMs (Figure 1).
Seventeen neurosurgical procedures were performed. 
In nine cases, it was the first-choice treatment. The remain-
ing ones were preceded by endovascular embolisation. 
Only one patient underwent two surgical procedures. Fif-
teen of 17 (88.24%) neurosurgical procedures had resulted 
in complete removal of the AVM. In both cases of unsuc-
cessful procedures not all feeding arteries were clipped.
Ninety-four endovascular embolisations were per-
formed. No patients were qualified for this procedure af-
ter surgical treatment. Fourteen procedures (14.89%) led 
to complete embolisation of the whole AVM in the first 
attempt. Sixty-five procedures (69.15%) led to complete 
embolisation of one feeding vessel, fulfilling the aim of the 
procedure, as a part of multistage treatment. Fifteen pro-
cedures (15.96%) were unsuccessful due to complex anat-
omy of feeding vessels (11 cases), extravasation of contrast 
(three cases), and intraoperative haemorrhage (one case).
Table 1. Summary of patients’ characteristics
Patients characteristics
Total patients 50
Men 32
Women 18
Performed procedures 111
Age, y, mean 38.20 (σ = 13.56)
Age, y, range 10-66
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Patients who underwent endovascular embolisation 
had higher early complication ratio (21.28%) than pa-
tients after neurosurgical operation (17.65%). Acute car-
diopulmonary failure, cerebral haemorrhage, and CSF 
subcutaneous collection occurred in three cases after sur-
gical procedure. Early complications after embolisation 
occurred in 20 cases (Table 2). In several cases more than 
one complication appeared. In majority complications 
were minor or transient which led to similar clinical con-
dition of patients in both groups on discharge – according 
to GOS (mean GOS: 5.00 in operation and 4.89 in the 
embolisation group).
Patients were hospitalised for approximately the same 
amount of time on ICU after neurosurgical (mean stay: 
0.35 days) and endovascular (mean stay: 0.49 days) pro-
cedure. However, undergoing neurosurgical procedure 
had impact on longer hospitalisation on the neurosurgery 
ward (10.59 days vs. 6.32 days, p < 0.01).
Patients who were evaluated as Spetzler-Martin scale 
grade 1 were more frequently qualified to neurosurgical 
procedure than patients in higher grades (Figure 2). Cer-
ebral haemorrhage was also observed more frequently as 
grade 1 (47.37% grade 1; 28.57% grade 2; 31.91% grade 3).
Higher Spetzler-Ponce scale scores (p = 0.02), elo-
quent localisation (p = 0.04), and deep cerebral localisa-
tion (p = 0.01) of the AVM were associated with lower 
GCS scores. Eloquent localisation of the AVM was also 
associated with longer hospitalisation on the neurosur-
gery ward (p = 0.02).
Spetzler-Martin scale, Spetzler-Ponce scale, eloquent 
localisation, and deep cerebral localisation had no influ-
ence on the effectiveness of the therapy, early complica-
tion rate, GOS score, and hospitalisation time on ICU.
Discussion
The incidence of neurological deficits and deaths caused 
by AVM treatment ranges from 0 to 20% (mean 8%) [10]. 
Optimal therapeutic strategy should be characterised by 
decreasing haemorrhage risk and alleviating neurological 
symptoms with an acceptable mortality and morbidity 
rate [11]. Complete obliteration of AVM is the main goal 
of the treatment because subtotal therapy does not confer 
protection from haemorrhage [5]. Nowadays four differ-
Figure 1. Classification of the arteriovenous malformations in Spetzler-Martin and Spetzler-Ponce scales
Grade 1 Grade 2 Grade 3 Grade 4 Grade 5 Grade A Grade B Grade C
47 47
3 3
19
42
61
A B
Table 2. Early complications after endovascular procedure
Complication Quantity
Cerebral haemorrhage 5
Subarachnoid haemorrhage 1
Paresis 3
Microcatheter breakdown 3
Inguinal haematoma 1
Anisocoria 1
Vision disorders 3
Hearing disorders 2
Increased intracranial pressure 1
Severe headaches 1
Severe nauseas 1
Figure 2. Impact of Spetzler-Martin scale on choosing first-choice treatment
0 20 40 60 80 100
[%]
Spetzler-
Martin 
grade 1
Spetzler-
Martin 
grade 2
Spetzler-
Martin 
grade 3
26.31 73.69
89.47
79.49
10.53
20.51
Neurosurgical procedure Endovascular procedure
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ent types of therapeutic approach are considered: micro-
surgical resection, endovascular embolisation, stereotac-
tic radiosurgery, and conservative management. These 
modalities could be applied alone or in combination 
[12,13]. Choosing the best therapeutic strategy could be 
difficult; however, making a decision whether the preven-
tive eradication of unruptured lesions is required seems 
to be the most significant dilemma connected with AVM 
treatment [14-16]. Results of the randomised clinical trial 
ARUBA show that the risk of stroke and death after the 
initiation of unruptured AVM invasive treatment is more 
than threefold higher than in patients treated conserva-
tively [17]; however, the study has important limitations, 
and its significance is discussed by some authors [18,19]. 
Due to literature controversies according to clinical out-
comes of invasive treatment of AVMs, we decided to 
present the data from our Centre. Additionally, we un-
dertook the assessment of the impact of Spetzler-Martin 
and Spetz ler-Ponce scales on qualification to endovascular 
embolisation or neurosurgical procedure.
The role of endovascular embolisation in AVM treat-
ment remains controversial. It appears to be useful in large 
or deeply located lesions, but at the same time some authors 
highlight significantly higher risk of complications occur-
ring during this procedure and worse outcomes in patients 
who have undergone preoperative embolisation [12,20]. On 
the other hand, according to the analysis of 33,997 patients 
diagnosed with AVM between 2001 and 2009 conducted 
by Davies et al., the proportion of AVMs treated endovas-
cularly is increasing [21]. In our study embolisation was 
the preferred treatment strategy in the majority of cases. 
Our data suggest that risk of morbidity is higher for em-
bolisation than for surgical intervention. At the same time 
patients treated surgically tend to stay in hospital longer, 
which was also proven by other authors [21].
The Spetzler-Martin grading system was designed 
to predict the outcome of surgical treatment [7,22]. Our 
study confirms its usefulness in treatment planning; 
however, Spetzler-Martin and Spetzler-Ponce scores do 
not impact the effectiveness of therapy. Recommended 
management for AVMs in grade I and II is microsurgical 
removal, while IV and V grade lesions should be treated 
conservatively [23]. Surprisingly, in the analysed group 
a higher percentage of AVMs treated surgically was ob-
served in grade III than in grade II. On that basis, it could 
be concluded that neurosurgeons take the Spetzler-Martin 
grading system into consideration too rarely. It should be 
mentioned that Spetzler-Martin criteria do not include 
morphologic features like the number of feeding arteries 
or the presence of associated aneurysms (which have an 
impact on haemorrhage risk), and there are no reliable 
data correlating these factors and treatment outcome [5]. 
The Spetzler-Martin system does not reflect the major 
determinants of risk associated with embolisation [24]. 
For this reason, other grading systems for endovascular 
therapy, assessing higher numbers of various data, should 
be used during qualification to invasive treatment (for 
example, Buffalo score, proposed by Dumont et al. in 
2014) [25].
According to our results, there is no correlation between 
deep or eloquent brain location and treatment outcome or 
early complications rate. It should be emphasised that the 
definition of “brain eloquence” is not clear enough – there 
are differences in its interpretation, which result in variable 
coding [26] and make comparing data obtained from dif-
ferent units difficult. The univariate analysis performed by 
Hartman et al. revealed that more frequent embolisations, 
no neurological deficit at baseline, non-haemorrhagic AVM 
presentation, large AVM diameter, Spetzler-Martin score, 
deep venous drainage, and eloquent AVM location were 
associated with long-term treatment-related neurological 
deficits [10].
Our study, as a retrospective survey, is associated with 
the necessity of being based on previously collected data 
only. Therefore, some patients must have been excluded 
from the study due to lack of data. Including those pa-
tients, if the data were complete, may have had an influ-
ence on the final results of this study. Moreover, we were 
not able to evaluate long-term complications of treatment, 
which is an important limitation. It was not possible to 
assess the risk of haemorrhage after embolisation and 
surgical intervention in our patients’ due to lack of long-
term follow-up. What is more, we analysed only two ther-
apeutic strategies, because radiosurgery is not available 
in our Unit. Due to lack of sufficient and conclusive data 
concerning the necessity of invasive treatment and sub-
sequent qualification to one of the treatment methods, 
further studies in this area should be performed.
Conclusions
Treating AVMs requires coordination of a multidiscipli-
nary team. Both endovascular embolisation and neuro-
surgical procedure should be considered as part of multi-
modal, frequently multistage treatment. Spetzler-Martin 
and Spetzler-Ponce scales have an influence on haem-
orrhage frequency and patients’ clinical condition and 
should be taken into consideration in selecting the treat-
ment method.
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